BRISTOL-MYERS SQUIBB COMPANY Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-17.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2012-02-17
- BRISTOL-MYERS SQUIBB COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2009-12-31 was $3.66.
- BRISTOL-MYERS SQUIBB COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2009-09-30 was $0.04.
- BRISTOL-MYERS SQUIBB COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2009-06-30 was $0.05.
- BRISTOL-MYERS SQUIBB COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2009-03-31 was -$0.01.
- BRISTOL-MYERS SQUIBB COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2011 was $0.00.
- BRISTOL-MYERS SQUIBB COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2010 was $0.00, a 100.00% decline from fiscal 2009.
- BRISTOL-MYERS SQUIBB COMPANY income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2009 was $3.72.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-02-17 | |
| 2010-12-31 | $0.00 10-K · filed 2012-02-17 | |
| 2009-12-31 | $3.66 10-K · filed 2011-02-18 | $3.72 10-K · filed 2012-02-17 |
| 2009-09-30 | $0.04 10-K · filed 2011-02-18 | |
| 2009-06-30 | $0.05 10-K · filed 2011-02-18 | |
| 2009-03-31 | -$0.01 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |